Page 21 - Service Testing News Today

Company will halt development of experimental depression treatment

By Colin Kellaher Ikena Oncology shares lost more than two-thirds of their value and hit an all-time low after the clinical-stage biotechnology company...

Zepbound helped patients lose up to 48 pounds on average in clinical trials.

By Stephen Nakrosis Aura Biosciences on Monday said it received agreement from the U.S. Food and Drug Administration for the design and plan of a Phase 3...

By Dean Seal Shares of Werewolf Therapeutics shot higher after the company presented Phase 1 trial data establishing proof of mechanism for its lead clinical...

By Josh Beckerman Shares of Candel Therapeutics fell to a 52-week low after the cancer-focused biopharmaceutical company reported interim data from a...

By Ben Glickman TC BioPharm Holdings has reached a deal for Fortrea to manage its global clinical trials, the latest cost-cutting effort by the...

By Colin Kellaher Kronos Bio is shedding about 19% of its staff as the clinical-stage biopharmaceutical moves to extend its cash runway following positive...

By Stephen Nakrosis Nurix Therapeutics on Wednesday said the Food and Drug Administration placed a partial clinical hold on U.S. Phase 1 NX-2127-001 study...

By Rob Curran Biotech company Mersana Therapeutics said the Food and Drug Administration lifted a clinical hold on a Phase 1 trial of one of its...